Intravenous immunoglobulin therapy: how does IgG modulate the immune system?
- PMID: 23411799
- DOI: 10.1038/nri3401
Intravenous immunoglobulin therapy: how does IgG modulate the immune system?
Abstract
Intravenous immunoglobulin (IVIG) preparations comprise pooled IgG antibodies from the serum of thousands of donors and were initially used as an IgG replacement therapy in immunocompromised patients. Since the discovery, more than 30 years ago, that IVIG therapy can ameliorate immune thrombocytopenia, the use of IVIG preparations has been extended to a wide range of autoimmune and inflammatory diseases. Despite the broad efficacy of IVIG therapy, its modes of action remain unclear. In this Review, we cover the recent insights into the molecular and cellular pathways that are involved in IVIG-mediated immunosuppression, with a particular focus on IVIG as a therapy for IgG-dependent autoimmune diseases.
Comment in
-
Reply to - IVIG pluripotency and the concept of Fc-sialylation: challenges to the scientist.Nat Rev Immunol. 2014 May;14(5):349. doi: 10.1038/nri3401-c2. Nat Rev Immunol. 2014. PMID: 24762828 No abstract available.
-
IVIG pluripotency and the concept of Fc-sialylation: challenges to the scientist.Nat Rev Immunol. 2014 May;14(5):349. doi: 10.1038/nri3401-c1. Nat Rev Immunol. 2014. PMID: 24762829 No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
